{"id":"0c9db068-407d-4cba-ad54-55f57bb98139","timestamp":1775580027274,"matcher":{"static":{},"wildcard":{},"dynamic":{}},"prerendered":["/approach","/","/clients","/team","/insights","/privacy","/legal","/contact","/team/sabrina-poulos","/sitemap","/team/stephanie-dusaban-gonzales","/team/kristin-havranek","/team/bonnie-choi","/team/jennifer-floyd","/team/jamie-gleason-bremer","/team/daniel-kolker","/team/victoria-r-tenge","/team/sakshi-uppal","/team/jenniffer-huddleston","/team/jesse-fermin","/insights/sarepta-seeks-en-banc-review-of-federal-circuit-ruling-in-regenxbio-case","/insights/new-patent-rules-ease-protection-of-digital-interfaces-and-immersive-tech","/insights/federal-circuit-holds-regenxbios-gene-therapy-claims-eligible-under-101","/insights/supreme-court-declines-to-review-msn-v-novartis-after-arising-tech-case","/insights/supreme-court-grants-certiorari-in-hikma-v-amarin-skinny-label-case","/insights/us-solicitor-general-urges-supreme-court-review-of-hikma-v-amarin-case","/insights/new-guidance-on-patent-eligibility-for-software-and-ai-innovations","/insights/federal-circuit-overturns-seagens-42m-patent-win-against-enhertu","/insights/update-on-ai-at-the-uspto","/insights/ymtc-and-the-entity-list-what-this-means-for-iprs","/insights/what-this-transcatheter-valve-patent-dispute-means-for-your-ip-strategy","/insights/updates-to-ipr-practice-at-the-uspto-create-new-path-to-challenge-iprs","/insights/a-turning-point-for-ai-patent-eligibility-at-the-uspto","/insights/regenxbio-inc-v-sarepta-therapeutics-inc","/insights/MSN-v-Novartis","/expertise/therapeutics","/expertise/medical-devices","/expertise/tissue-and-cell-engineering","/expertise/foodtech","/expertise/diagnostics","/expertise/digital-health"]}